Jason Scharf

Founder, Podcast Host, and Ecosystem Builder

In an era where biology, tech, and business intersect, I offer a unique blend of strategic foresight, entrepreneurial acumen, and incisive questioning. Through key roles at industry leaders like Illumina, Becton Dickinson, and Amgen, I’ve honed a systems-thinking approach, turning complex data into actionable insights.

As an angel investor, I have back game-changing startups in Digital Health & TechBio sectors. My portfolio includes Pleno, Iridia, Abterra Biosciences, Syntrillo, and Elicio Therapeutics—a recent Nasdaq exit. These investments reflect my commitment to the convergence of technology and biology, consumer-driven health solutions, and the rise of the Texas Triangle as the next bio innovation hubs.

Beyond my investment activities, I host the Austin Next Podcast. The show explores Austin’s emergence as an innovation powerhouse, delves into broader technology shifts, and uncovers the underlying mechanics of innovation ecosystems. My writings on Austin’s Bio+Health scene, venture capital, and global trends are catalyzing important conversations.